Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease

Neurology

Volumn 72, Issue 16, 2009, Pages 1425-1431

  Manners, D N ^b   Parchi, P ^a   Tonon, C ^b   Capellari, S ^a   Strammiello, R ^a   Testa, C ^b   Tani, G ^a   Malucelli, E ^b   Spagnolo, C ^a   Cortelli, P ^a   Montagna, P ^a   Lodi, R ^a,b   Barbiroli, B ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b MR Spectroscopy Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN SPONGIOSIS; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CREUTZFELDT JAKOB DISEASE; DIFFUSION WEIGHTED IMAGING; FEMALE; GLIOSIS; HUMAN; MALE; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PARIETAL LOBE; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TEMPORAL CORTEX; THALAMUS; BASAL GANGLION; BRAIN; BRAIN CORTEX; BRAIN MAPPING; DISEASE COURSE; IMAGE PROCESSING; METHODOLOGY; MIDDLE AGED; NERVE DEGENERATION; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING;

ADULT; AGED; AUTOPSY; BASAL GANGLIA; BRAIN; BRAIN MAPPING; CEREBRAL CORTEX; CREUTZFELDT-JAKOB SYNDROME; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; FEMALE; GLIOSIS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NERVE DEGENERATION; PREDICTIVE VALUE OF TESTS; THALAMUS;

EID: 67449147069     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181a18846     Document Type: Article

References (25)

1. Johnson RT, Gibbs CJ Jr. Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med 1998;339:1994-2004.
2. Kretzschmar HA, Parchi P. Pathology and genetics of human prion diseases. In: Hoernlimann B, Riesner D, Kretzschmar H, eds. Prions in Humans and Animals: Pathology and Genetics of Human Prion Diseases. Berlin: De Gruyter Press; 2007:287-305.
3. Parchi P, Castellani R, Capellari S, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996;39:767-78.
4. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224-33.
5. Macfarlane RG, Wroe SJ, Collinge J, Yousry TA, Jager HR. Neuroimaging findings in human prion disease. J Neurol Neurosurg Psychiatry 2007;78:664-670.
6. Shiga Y, Miyazawa K, Sato S, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004;63:443-449.
7. Young GS, Geschwind MD, Fischbein NJ, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 2005;26:1551-1562.
8. Tschampa HJ, Kallenberg K, Kretzschmar HA, et al. Pattern of cortical changes in sporadic Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol 2007;28:1114-1118.
9. Bahn MM, Parchi P. Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease. Arch Neurol 1999;56:577-583.
10. Murata T, Shiga Y, Higano S, Takahashi S, Mugikura S. Conspicuity and evolution of lesions in Creutzfeldt-Jakob disease at diffusion-weighted imaging. AJNR Am J Neuroradiol 2002;23:1164-1172.
11. Tschampa HJ, Mürtz P, Flacke S, Paus S, Schild HH, Urbach H. Thalamic involvement in sporadic Creutzfeldt-Jakob disease: a diffusion-weighted MR imaging study. AJNRAm J Neuroradiol 2003;24:908-915.
12. Russmann H, Vingerhoets F, Miklossy J, et al. Sporadic Creutzfeldt-Jakob disease: a comparison of pathological findings and diffusion weighted imaging. J Neurol 2005; 252:338-342.
13. Gertz HJ, Henkes H, Cervos-Navarro J. Creutzfeldt-Jakob disease: correlation of MRI and neuropathologic findings. Neurology 1988;38:1481-1482.
14. Urbach H, Klisch J, Wolf HK, Brechtelsbauer D, Gass S, Solymosi L. MRI in sporadic Creutzfeldt-Jakob disease: correlation with clinical and neuropathological data. Neuroradiol 1998;40:65-70.
15. Mittal S, Farmer P, Kalina P, et al. Correlation of diffusion-weighted magnetic resonance imaging with neuropathology in Creutzfeldt-Jakob disease. Arch Neurol 2002;59:128-134.
16. Zerr I, Pocchiari M, Collins S, et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000;55:811-815.
17. Masters CL, Richardson EP Jr. Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease): the nature and progression of spongiform change. Brain 1978; 101: 333-344.
18. Parchi P, Castellani R, Cortelli P, et al. Regional distribution of pro tease-resistant prion protein in fatal familial insomnia. Ann Neurol 1995;38:21-29.
19. Ferrer I, Armstrong J, Capellari S, et al. Effects of formalin fixation, paraffin embedding, and time of storage on DNA preservation in brain tissue: a BrainNet Europe Study. Brain Pathol 2007;17:297-303.
20. Samman I, Schulz-Schaeffer WJ, Wohrle JC, Sommer A, Kretzschmar HA, Hennerici M. Clinical range and MRI in Creutzfeldt-Jakob disease with heterozygosity at codon 129 and prion protein type 2. J Neurol Neurosurg Psychiatry 1999;67:678-681.
21. Haik S, Dormont D, Faucheux BA, Marsault C, Hauw JJ. Prion protein deposits match magnetic resonance imaging signal abnormalities in Creutzfeldt-Jakob disease. Ann Neurol 2002;51:797-799.
22. Jeffrey M, Goodsir CM, Bruce ME, McBride PA, Scott JR, Halliday WG. Infection specific prion protein (PrP) accumulates on neuronal plasmalemma in scrapie infected mice. Neurosci Lett 1992;147:106-109.
23. Mallucci G, Collinge J. Update on Creutzfeldt-Jakob disease. Curr Opin Neurol 2004;17:641-647.
24. Broom KA, Anthony DC, Lowe JP, et al. MRI and MRS alterations in the preclinical phase of murine prion disease: association with neuropathological and behavioural changes. Neurobiol Dis 2007;26:707-717.
25. Chung YL, Williams A, Ritchie D, et al. Conflicting MRI signals from gliosis and neuronal vacuolation in prion diseases. Neuroreport 1999;10:3471-3477.